Structure-based kinetic models of modular signaling protein function: Focus on Shp2

Biophysical Journal

Volumn 92, Issue 7, 2007, Pages 2290-2300

  Barua, Dipak ^a   Faeder, James R ^b   Haugh, Jason M ^a  

^a North Carolina State University   (United States)

^b LOS ALAMOS NATIONAL LABORATORY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN TYROSINE PHOSPHATASE SHP 2;

ARTICLE; ENZYME ACTIVITY; KINETICS; MATHEMATICAL MODEL; MOLECULAR DYNAMICS; PROTEIN BINDING; PROTEIN INTERACTION; PROTEIN PHOSPHORYLATION; PROTEIN STRUCTURE; SIGNAL TRANSDUCTION;

EID: 34047224747     PISSN: 00063495     EISSN: None     Source Type: Journal    
DOI: 10.1529/biophysj.106.093484     Document Type: Article

References (59)

1. Tonks, N.K., and B. G. Neel. 2001. Combinatorial control of the specificity of protein tyrosine phosphatases. Curr. Opin. Cell Biol. 13:182-195.
2. van der Geer, P., T. Hunter, and R. A. Lindberg. 1994. Receptor protein-tyrosine kinases and their signal transduction pathways. Annu. Rev. Cell Biol. 10:251-337.
3. Schlessinger, J. 2000. Cell signaling by receptor tyrosine kinases. Cell. 103:211-225.
4. Hunter, T. 2000. Signaling - 2000 and beyond. Cell. 100:113-127.
5. Pawson, T. 2004. Specificity in signal transduction: from phosphotyrosine-SH2 domain interactions to complex cellular systems. Cell. 116:191-203.
6. Bhattacharyya, R. P., A. Remenyi, B. J. Yeh, and W. A. Lim. 2006. Domains, motifs, and scaffolds: the role of modular interactions in the evolution and wiring of cell signaling circuits. Annu. Rev. Biochem. 75:655-680.
7. Neel, B. G., H. H. Gu, and L. Pao. 2003. The 'Shp'ing news: SH2 domain-containing tyrosine phosphatases in cell signaling. Trends Biochem. Sci. 28:284-293.
8. Klinghoffer, R. A., and A. Kazlauskas. 1995. Identification of a putative Syp substrate, the PDGFβ receptor. J. Biol. Chem. 270: 22208-22217.
9. Ekman, S., A. Kallin, A. Engström, and C.-H. Heldin. 2002. SHP-2 is involved in heterodimer specific loss of phosphorylation of Tyr771 in the PDGF β-receptor. Oncogene. 21:1870-1875.
10. Agazie, Y. M., and M. J. Hayman. 2003. Molecular mechanism for a role of SHP2 in epidermal growth factor receptor signaling. Mol. Cell. Biol. 23:7875-7886.
11. Hof, P., S. Pluskey, S. Dhe-Paganon, M. J. Eck, and S. E. Shoelson. 1998. Crystal structure of the tyrosine phosphatase SHP-2. Cell. 92:441-450.
12. Barford, D., and B. G. Neel. 1998. Revealing mechanisms for SH2 domain mediated regulation of the protein tyrosine phosphatase SHP-2. Structure. 6:249-254.
13. Lechleider, R. J., S. Sugimoto, A. M. Bennett, A. S. Kashishian, J. A. Cooper, S. E. Shoelson, C. T. Walsh, and B. G. Neel. 1993. Activation of the SH2-containing phosphotyrosine phosphatase SH-PTP2 by its binding site, phosphotyrosine 1009, on the human platelet-derived growth factor receptor. J. Biol. Chem. 268:21478-21481.
14. Dechert, U., M. Adam, K. W. Harder, I. Clark-Lewis, and F. Jirik. 1994. Characterization of protein tyrosine phosphatase SH-PTP2: study of phosphopeptide substrates and possible regulatory role of SH2 domains. J. Biol. Chem. 269:5602-5611.
15. Sugimoto, S., T. J. Wandless, S. E. Shoelson, B. G. Neel, and C. T. Walsh. 1994. Activation of the SH2-containing protein tyrosine phosphatase, SH-PTPs by phosphotyrosine-containing peptides derived from insulin receptor substrate-1. J. Biol. Chem. 269:13614-13622.
16. Pei, D. H., J. Wang, and C. T. Walsh. 1996. Differential functions of the two Src homology 2 domains in protein tyrosine phosphatase SH-PTP1. Proc. Natl. Acad. Sci. USA. 93:1141-1145.
17. Keilhack, H., F. S. David, M. McGregor, L. C. Cantley, and B. G. Neel. 2005. Diverse biochemical properties of Shp2 mutants: implications for disease phenotypes. J. Biol. Chem. 280:30984-30993.
18. Pluskey, S., T. J. Wandless, C. T. Walsh, and S. E. Shoelson. 1995. Potent stimulation of SHPTPs phosphatase activity by simultaneous occupancy of both SH2 domains. J. Biol. Chem. 270:2897-2900.
19. Eck, M. J., S. Pluskey, T. Trub, S. C. Harrison, and S. E. Shoelson. 1996. Spatial constraints on the recognition of phosphoproteins by the tandem SH2 domains of the phosphatase SH-PTP2. Nature. 379:277-280.
20. Ottinger, E. A., M. C. Botfield, and S. E. Shoelson. 1998. Tandem SH2 domains confer high specificity in tyrosine kinase signaling. J. Biol. Chem. 273:729-735.
21. Cunnick, J. M., L. Mei, C. A. Doupnik, and J. Wu. 2001. Phosphotyrosines 627 and 659 of Gab1 constitute a bisphosphoryl tyrosine-based activation motif (BTAM) conferring binding and activation of SHP2. J. Biol. Chem. 276:24380-24387.
22. Feng, G., C. Hui, and T. Pawson. 1993. SH2-containing phosphotyrosine phosphatase as a target of protein-tyrosine kinases. Science. 259:1607-1610.
23. Vogel, W., R. Lammers, J. Huang, and A. Ullrich. 1993. Activation of a phosphotyrosine phosphatase by tyrosine phosphorylation. Science. 259:1611-1614.
24. Araki, T., H. Nawa, and B. G. Neel. 2003. Tyrosyl phosphorylation of Shp2 is required for normal ERK activation in response to some, but not all, growth factors. J. Biol. Chem. 278:41677-41684.
25. Lu, W., D. Q. Gong, D. Bar-Sagi, and P. A. Cole. 2001. Site-specific incorporation of a phosphotyrosine mimetic reveals a role for tyrosine phosphorylation of SHP-2 in cell signaling. Mol. Cell. 8:759-769.
26. Zhang, Z. S., K. Shen, W. Lu, and P. A. Cole. 2003. The role of C-terminal tyrosine phosphorylation in the regulation of SHP-1 explored via expressed protein ligation. J. Biol. Chem. 278:4668-4674.
27. Lu, W., K. Shen, and P. A. Cole. 2003. Chemical dissection of the effects of tyrosine phosphorylation of SHP-2. Biochemistry. 42:5461-5468.
28. Bennett, A. M., T. L. Tang, S. Sugimoto, C. T. Walsh, and B. G. Neel. 1994. Protein-tyrosine-phosphatase SHPTP2 couples platelet-derived growth factor receptor β to Ras. Proc. Natl. Acad. Sci. USA. 91:7335-7339.
29. Li, W., R. Nishimura, A. Kashishian, A. G. Batzer, W. J. H. Kim, J. A. Cooper, and J. Schlessinger. 1994. A new function for a phosphotyrosine phosphatase: linking Grb2-Sos to a receptor tyrosine kinase. Mol. Cell. Biol. 14:509-517.
30. Weng, G., U. S. Bhalla, and R. Iyengar. 1999. Complexity in biological signaling systems. Science. 284:92-96.
31. Kholodenko, B. N. 2006. Cell-signalling dynamics in time and space. Nat. Rev. Mol. Cell Biol. 7:165-176.
32. Hlavacek, W. S., J. R. Faeder, M. L. Blinov, A. S. Perelson, and B. Goldstein. 2003. The complexity of complexes in signal transduction. Biotechnol. Bioeng. 84:783-794.
33. Faeder, J. R., W. S. Hlavacek, I. Reischl, M. L. Blinov, H. Metzger, A. Redondo, C. Wofsy, and B. Goldstein. 2003. Investigation of early events in FceRI-mediated signaling using a detailed mathematical model. J. Immunol. 170:3769-3781.
34. Blinov, M. L., J. R. Faeder, B. Goldstein, and W. S. Hlavacek. 2004. BioNetGen: software for rule-basedmodeling of signal transduction based on the interactions of molecular domains. Bioinformatics. 20:3289-3291.
35. Lok, L., and R. Brent. 2005. Automatic generation of cellular reaction networks with Moleculizer 1.0. Nat. Biotechnol. 23:131-136.
36. Conzelmann, H., J. Saez-Rodriguez, T. Sauter, B. N. Kholodenko, and E. D. Gilles. 2006. A domain-oriented approach to the reduction of combinatorial complexity in signal transduction networks. BMC Bioinformatics. 7:34.
37. Hlavacek, W. S., J. R. Faeder, M. L. Blinov, R. G. Posner, M. Hucka, and W. Fontana. 2006. Rules for modeling signal-transduction systems. Sci. STKE. 344:re6.
38. Haugh, J. M., I. C. Schneider, and J. M. Lewis. 2004. On the crossregulation of protein tyrosine phosphatases and receptor tyrosine kinases in intracellular signaling. J. Theor. Biol. 230:119-132.
39. Kazlauskas, A., G. S. Feng, T. Pawson, and M. Valius. 1993. The 64-kDa protein that associates with the platelet-derived growth factor receptor β subunit via Tyr-1009 is the SH2-containing phosphotyrosine phosphatase Syp. Proc. Natl. Acad. Sci. USA. 90:6939-6942.
40. Haugh, J. M., and D. A. Lauffenburger. 1998. Analysis of receptor internalization as a mechanism for modulating signal transduction. J. Theor. Biol. 195:187-218.
41. ras in fibroblasts. J. Biol. Chem. 274:34350-34360.
42. Ladbury, J. E., M. A. Lemmon, M. Zhou, J. Green, M. C. Botfield, and J. Schlessinger. 1995. Measurement of the binding of tyrosyl phosphopeptides to SH2 domains: a reappraisal. Proc. Natl. Acad. Sci. USA. 92:3199-3203.
43. Valitutti, S., S. Muller, M. Cella, E. Padovan, and A. Lanzavecchia. 1995. Serial triggering of many T-cell receptors by a few peptide-MHC complexes. Nature. 375:148-151.
44. Valitutti, S., and A. Lanzavecchia. 1997. Serial triggering of TCRs: a basis for the sensitivity and specificity of antigen recognition. Immunol. Today. 18:299-304.
45. Coombs, D., A. M. Kalergis, S. G. Nathenson, C. Wofsy, and B. Goldstein. 2002. Activated TCRs remain marked for internalization after dissociation from pMHC. Nat. Immunol. 3:926-931.
46. Saxton, T. M., M. Henkemeyer, S. Gasca, R. Shen, D. J. Rossi, F. Shalaby, G. Feng, and T. Pawson. 1997. Abnormal mesoderm patterning in mouse embryos mutant for the SH2 tyrosine phosphatase Shp-2. EMBO J. 16:2352-2364.
47. Qu, C., Z. Shi, R. Shen, F. Tsai, S. H. Orkin, and G. Feng. 1997. A deletion mutation in the SH2-N domain of Shp-2 severely suppresses hematopoietic cell development. Mol. Cell. Biol. 17:5499-5507.
48. 2-terminal mitogen-activated protein kinases. J. Biol. Chem. 273:4904-4908.
49. Shi, Z., D. Yu, M. Park, M. Marshall, and G. Feng. 2000. Molecular mechanism for the Shp-2 tyrosine phosphatase function in promoting growth factor stimulation of Erk activity. Mol. Cell. Biol. 20:1526-1536.
50. Yang, W., L. D. Klaman, B. Chen, T. Araki, H. Harada, S. M. Thomas, E. L. George, and B. G. Neel. 2006. An Shp2/SFK/Ras/Erk signaling pathway controls trophoblast stem cell survival. Dev. Cell. 10:317-327.
51. Tartaglia, M., E. L. Mehler, R. Goldberg, G. Zampino, H. G. Brunner, H. Kremer, I. van der Burgt, A. H. Crosby, A. Ion, S. Jeffery, K. Kalidas, M. A. Patton, R. S. Kucherlapati, and B. D. Gelb. 2001. Mutations in PTPN11, encoding the protein tyrosine phosphatase SHP-2, cause Noonan syndrome. Nat. Genet. 29:465-468.
52. O'Reilly, A. M., S. Pluskey, S. E. Shoelson, and B. G. Neel. 2000. Activated mutants of SHP-2 preferentially induce elongation of Xenopus animal caps. Mol. Cell. Biol. 20:299-311.
53. Araki, T., M. G. Mohi, F. A. Ismat, R. T. Bronson, I. R. Williams, J. L. Kutok, W. T. Yang, L. I. Pao, D. G. Gilliland, J. A. Epstein, and B. G. Neel. 2004. Mouse model of Noonan syndrome reveals cell type- and gene dosage-dependent effects of Ptpn11 mutations. Nat. Med. 10:849-857.
54. Mohi, M. G., I. R. Williams, C. R. Dearolf, G. Chan, J. L. Kutok, S. Cohen, K. Morgan, C. Boulton, H. Shigematsu, H. Keilhack, K. Akashi, D. G. Gilliland, and B. G. Neel. 2005. Prognostic, therapeutic, and mechanistic implications of a mouse model of leukemia evoked by Shp2 (PTPN11) mutations. Cancer Cell. 7:179-191.
55. Chan, R. J., M. B. Leedy, V. Munugalavadla, C. S. Voorhorst, Y. J. Li, M. G. Yu, and R. Kapur. 2005. Human somatic PTPN11 mutations induce hematopoietic-cell hypersensitivity to granulocyte-macrophage colony-stimulating factor. Blood. 105:3737-3742.
56. Yu, W. M., H. Daino, J. Chen, K. D. Bunting, and C. K. Qu. 2006. Effects of a leukemia-associated gain-of-function mutation of SHP-2 phosphatase on interleukin-3 signaling. J. Biol. Chem. 281:5426-5434.
57. Gu, H. H., and B. G. Neel. 2003. The 'Gab' in signal transduction. Trends Cell Biol. 13:122-130.
58. Northrup, S. H., and H. P. Erickson. 1992. Kinetics of protein-protein association explained by Brownian dynamics computer simulation. Proc. Natl. Acad. Sci. USA. 89:3338-3342.
59. Sugimoto, S., R. J. Lechleider, S. E. Shoelson, B. G. Neel, and C. T. Walsh. 1993. Expression, purification, and characterization of SH2-containing protein tyrosine phosphatase, SH-PTP2. J. Biol. Chem. 268:22771-22776.